Analyses using human CRC transcriptomic databases and immunohistological staining of tissue array corroborated the strong clinical relevance of Gal-1 and SOX9—particularly Gal-1high/SOX9high samples—as significantly and prognostically correlated with disease presence and progression. This evidence concerns the gene SOX9 and colorectal carcinoma.